SMS ???? ? wrote:
> There are some good case studies of pricing in the Harvard Business
> Review. The Tagamet versus Zantac is a classic.

Is that on line somewhere? I've always had a suspicion that Tagamet was
the start of the outrageous pricing of drugs we see today. I remember it
was $30 a month as opposed to a typically expensive prescription of $12
or thereabouts. I remember also that they promised the price would drop
like a rock when R&D was paid off, but the price did nothing but go up,
quintupling just before a generic became available.

--
Dec. 6 (Bloomberg) -- Government officials and activists flying to Bali,
Indonesia, for the United Nations meeting on climate change will cause
as much pollution as 20,000 cars in a year.